These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 27901049

  • 1. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs).
    Rimando MG, Wu HH, Liu YA, Lee CW, Kuo SW, Lo YP, Tseng KF, Liu YS, Lee OK.
    Sci Rep; 2016 Nov 30; 6():37371. PubMed ID: 27901049
    [Abstract] [Full Text] [Related]

  • 2. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation.
    Liu P, Baumgart M, Groth M, Wittmann J, Jäck HM, Platzer M, Tuckermann JP, Baschant U.
    Sci Rep; 2016 Aug 24; 6():32112. PubMed ID: 27554624
    [Abstract] [Full Text] [Related]

  • 3. ACY‑1215, a HDAC6 inhibitor, decreases the dexamethasone‑induced suppression of osteogenesis in MC3T3‑E1 cells.
    Wang N, Wang H, Chen J, Wang F, Wang S, Zhou Q, Ying J, Huang S, Wang P, Yuan F.
    Mol Med Rep; 2020 Sep 24; 22(3):2451-2459. PubMed ID: 32705192
    [Abstract] [Full Text] [Related]

  • 4. Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells.
    Johnson TE, Vogel R, Rutledge SJ, Rodan G, Schmidt A.
    Endocrinology; 1999 Jul 24; 140(7):3245-54. PubMed ID: 10385421
    [Abstract] [Full Text] [Related]

  • 5. Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells.
    Ma X, Zhang X, Jia Y, Zu S, Han S, Xiao D, Sun H, Wang Y.
    Int Orthop; 2013 Jul 24; 37(7):1399-404. PubMed ID: 23645083
    [Abstract] [Full Text] [Related]

  • 6. Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss.
    Shen GY, Ren H, Shang Q, Zhao WH, Zhang ZD, Yu X, Huang JJ, Tang JJ, Yang ZD, Liang D, Jiang XB.
    Int J Biol Sci; 2019 Jul 24; 15(10):2182-2197. PubMed ID: 31592234
    [Abstract] [Full Text] [Related]

  • 7. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells.
    Subramaniam M, Colvard D, Keeting PE, Rasmussen K, Riggs BL, Spelsberg TC.
    J Cell Biochem; 1992 Dec 24; 50(4):411-24. PubMed ID: 1469072
    [Abstract] [Full Text] [Related]

  • 8. Dexamethasone suppresses osteogenesis of osteoblast via the PI3K/Akt signaling pathway in vitro and in vivo.
    Pan JM, Wu LG, Cai JW, Wu LT, Liang M.
    J Recept Signal Transduct Res; 2019 Feb 24; 39(1):80-86. PubMed ID: 31210570
    [Abstract] [Full Text] [Related]

  • 9. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y, Otsuka F, Takano M, Mukai T, Yamanaka R, Takeda M, Miyoshi T, Inagaki K, Sada KE, Makino H.
    Mol Cell Endocrinol; 2010 Aug 30; 325(1-2):118-27. PubMed ID: 20638987
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of heat shock protein 90 rescues glucocorticoid-induced bone loss through enhancing bone formation.
    Chen H, Xing J, Hu X, Chen L, Lv H, Xu C, Hong D, Wu X.
    J Steroid Biochem Mol Biol; 2017 Jul 30; 171():236-246. PubMed ID: 28408351
    [Abstract] [Full Text] [Related]

  • 11. Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo.
    Hildebrandt S, Baschant U, Thiele S, Tuckermann J, Hofbauer LC, Rauner M.
    Sci Rep; 2018 Jun 07; 8(1):8711. PubMed ID: 29880826
    [Abstract] [Full Text] [Related]

  • 12. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP, Mishra JS, Sharan K, Yadav M, Singh AK, Srivastava A, Kumar S, Bhaduaria S, Maurya R, Sanyal S, Chattopadhyay N.
    Phytomedicine; 2013 Nov 15; 20(14):1256-66. PubMed ID: 23928508
    [Abstract] [Full Text] [Related]

  • 13. Glucocorticoids impair bone formation of bone marrow stromal stem cells by reciprocally regulating microRNA-34a-5p.
    Kang H, Chen H, Huang P, Qi J, Qian N, Deng L, Guo L.
    Osteoporos Int; 2016 Apr 15; 27(4):1493-1505. PubMed ID: 26556739
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells.
    Atmani H, Audrain C, Mercier L, Chappard D, Basle MF.
    J Cell Biochem; 2002 Apr 15; 85(3):640-50. PubMed ID: 11968004
    [Abstract] [Full Text] [Related]

  • 15. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.
    Li H, Li T, Fan J, Li T, Fan L, Wang S, Weng X, Han Q, Zhao RC.
    Cell Death Differ; 2015 Dec 15; 22(12):1935-45. PubMed ID: 26206089
    [Abstract] [Full Text] [Related]

  • 16. Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells.
    Hong D, Chen HX, Xue Y, Li DM, Wan XC, Ge R, Li JC.
    J Steroid Biochem Mol Biol; 2009 Aug 15; 116(1-2):86-92. PubMed ID: 19460432
    [Abstract] [Full Text] [Related]

  • 17. Glucocorticoids antagonize RUNX2 during osteoblast differentiation in cultures of ST2 pluripotent mesenchymal cells.
    Koromila T, Baniwal SK, Song YS, Martin A, Xiong J, Frenkel B.
    J Cell Biochem; 2014 Jan 15; 115(1):27-33. PubMed ID: 23943595
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dexamethasone regulation of cFos mRNA in osteoprogenitors.
    Shur I, Socher R, Benayahu D.
    J Cell Physiol; 2005 Jan 15; 202(1):240-5. PubMed ID: 15389524
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of VK2 on glucocorticoid-treated MC3T3-E1 cells.
    Zhang YL, Yin JH, Ding H, Zhang W, Zhang CQ, Gao YS.
    Int J Mol Med; 2017 Jan 15; 39(1):160-166. PubMed ID: 27909721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.